Introduction
============

With the recent development of endoscopic submucosal dissection (ESD), en bloc resection of mucosal gastric cancer is now theoretically possible regardless of the size, shape, or location of the tumors [@JR467-1]. Additionally, ESD enables en bloc resection of lesions with submucosal fibrosis such as lesions with ulcer scarring or residual lesions after endoscopic treatment [@JR467-1]. However, the number of complications related to ESD is reported to be higher than that of endoscopic mucosal resection (EMR) [@JR467-2] because of the technical difficulties of ESD. In particular, the size of mucosal resection has been reported to be significantly associated with the incidence of complications such as delayed bleeding, perforation, and stricture [@JR467-3] [@JR467-4] [@JR467-5] [@JR467-6] [@JR467-7] [@JR467-8] [@JR467-9]. Making the extent of resection in ESD as small as curatively possible is important to reduce the number of procedure-related complications. Therefore, precise evaluation of the horizontal extent of early gastric cancers (EGCs) during ESD is necessary.

In Japan, conventional endoscopy with white light imaging (WLI) and chromoendoscopy with indigo carmine are widely used for endoscopic evaluation of the horizontal extent of EGCs [@JR467-10]. Recently, magnifying endoscopy with narrow-band imaging (ME-NBI) has been reported to be useful for distinguishing cancerous lesions from non-cancerous lesions and for delineating the horizontal extent of EGCs [@JR467-11] [@JR467-12] [@JR467-13] [@JR467-14]. However, there are few reports which have objectively demonstrated the superiority of ME-NBI over chromoendoscopy for this purpose.

Nagahama et al. reported that, among EGCs with unclear margins through chromoendoscopy with indigo carmine, the entire horizontal margin could be accurately delineated in 72.6 % of these lesions using ME-NBI [@JR467-12]. However, their study was limited by the fact that it was not a direct comparison between the diagnostic accuracy of ME-NBI and chromoendoscopy, and by the fact that the accuracy of tumor delineation was not objectively assessed. The aim of this study was to objectively compare the accuracy of both modalities for determining the horizontal extent of EGCs.

Patients, materials and methods
===============================

This study was begun after approval by the Medical Ethics Committee of the University of Tokyo Hospital and registration in the University Hospital Medical Network Clinical Trial Registry (UMIN000007641) on 2 April 2012. Written informed consent for participation in this study was obtained from all subjects by their own free will.

Study subjects
--------------

The study subjects had EGCs treated by ESD, after giving informed consent, at the University of Tokyo Hospital between 11 April 2012 and 30 November 2013. The exclusion criteria were as follows: (1) adenocarcinomas of the esophagogastric junction, (2) cancers of a remnant stomach or a gastric tube, (3) residual cancers after endoscopic treatment, (4) type 0-I lesions (lesions which were composed of two or more elements, such as type 0-I + IIa, were included in the analysis), (5) cancers located in the greater curvature of the gastric body, (6) cancers which extended to the duodenum, (7) cancers less than 10 mm in diameter. ESD was indicated for EGCs or adenomas with a suspicion of adenocarcinoma (Group 4 by biopsy) that met the Gotoda criteria [@JR467-15]. The subjects were assigned to the oral-NBI (O-NBI) group or the oral-CE (O-CE) group by the envelope method. Two hundred sealed envelopes were prepared, 100 for the O-NBI group and 100 for the O-CE group, and an envelope was randomly picked from the box before ESD. There was no prior research showing the appropriate prediction of sample size so we determined the timing of study termination when the analyzable subjects exceeded 50 lesions in each arm.

Endoscopic procedure for delineation of EGCs
--------------------------------------------

All patients received preoperative endoscopic examination with ME-NBI and/or chromoendoscopy with indigo carmine before the treatment date, and biopsies were performed from the peri-lesion area unless they took anticoagulants. The tumor location, circumference, and macroscopic type were determined using conventional endoscopy with white light just before ESD and were described according to the Japanese Classification of Gastric Carcinoma -- 3 rd Edition [@JR467-16]. If the tumor was composed of two or more elements, the predominant macroscopic type was adopted.

In the O-NBI group, we first observed the oral side of the tumor with ME-NBI. We mainly used middle zoom observation, and the horizontal extent of the tumor was carefully determined based on changes in the microvascular patterns and/or microsurface patterns [@JR467-13] and a marking dot was placed on the oral delineation line of the tumor using the DualKnife (KD-650, Olympus, Tokyo, Japan). After that, 0.2 % indigo carmine was sprayed and we observed the anal side of the tumor with chromoendoscopy without magnification and determined the horizontal extent of the tumor. A marking dot was placed on the anal delineation line of the tumor ([Fig. 1](#FI467-1){ref-type="fig"}).

![ The oral or anal border of the tumor was observed with magnifying endoscopy with narrow-band imaging (ME-NBI) according to assignment, and a marking dot was placed on the visible delineation line. The other side of the tumor border was observed with chromoendoscopy, and a marking dot was placed on the visible delineation line.](10-1055-s-0042-107068-i467ei1){#FI467-1}

In the O-CE group, we first observed the anal side of the tumor with ME-NBI using middle zoom observation and a marking dot was placed on the anal delineation line of the tumor. After 0.2 % indigo carmine was sprayed, we observed the oral side of the tumor with chromoendoscopy and placed a marking dot on the oral delineation line.

The number of marking dots was determined according to the diameter of the tumor in the short axial direction, with one mark per centimeter. After that, ESD was performed as described in previous reports [@JR467-11] [@JR467-17]. A GIF-H260Z video gastroscope (Olympus, Tokyo, Japan) was used for evaluation of the horizontal extent of EGCs. A VIO 300 D electrosurgical generator (Erbe Elektromedizin, Tubingen, Germany) was used as the high frequency electrical generator. The delineation of tumor borders and placement of marking dots on tumor edges were performed by endoscopists who had certification from the Japan Gastroenterological Endoscopy Society.

Pathological assessment and judgment of accurate or inaccurate evaluation
-------------------------------------------------------------------------

After ESD, we identified the marking dots on the tumor borders of the resected specimens and inserted 23G needles on those markings to assist the microscopic recognition. Then the resected specimens were fixed in a formalin solution and were serially cut at 2-mm intervals. The section was made in a direction linking the marking dots on the oral or anal tumor border. However, lesions which required serial cuts in a different direction to evaluate the resection margin accurately were excluded from analysis. The marking dots were identified under microscopic observation. Marking dots which were located within 1 mm of the border of the tumor were defined as "accurate evaluation" of tumor delineation. If a marking dot was located more than ± 1 mm from the tumor border, it was defined as "inaccurate evaluation" ([Fig. 2](#FI467-2){ref-type="fig"}). We set the cutoff value which separated accurate or inaccurate evaluation as ±1 mm in view of the technical limitation of putting the marking dot on the endoscopically determined tumor border.

![ Judgment of accurate or inaccurate evaluation. **a** The section was made in a direction linking the marking dots on the oral and anal side of the tumor border. The marking dots were identified under microscopic observation. **b1** Marking dots which were located within 1 mm of the tumor border were defined as "accurate evaluation" of tumor delineation. **b2** If a marking dot was located more than ±1 mm from the tumor border, it was defined as "inaccurate evaluation".](10-1055-s-0042-107068-i467ei2){#FI467-2}

Histological type, tumor size, tumor depth, ulceration, lymphovascular infiltration, and horizontal tumor extent were assessed pathologically according to the Japanese Classification of Gastric Carcinoma -- 3 rd Edition [@JR467-16]. If the tumor exhibited multiple histological types, the predominant histological type was adopted. We also assessed the presence of a flat (0--IIb) component, the presence of diffuse-type adenocarcinoma, the presence of mixed histology, the difference in the mucosal height at the tumor border compared with the adjacent non-neoplastic mucosa (i. e. macroscopic type of the tumor border: elevated, flat, or depressed), the histological type of the tumor border, and the presence of marginal elevation. The presence of a flat (0--IIb) component meant that a tumor contained a flat component which could be recognized macroscopically on the resected specimen (e. g. 0--IIa + 0--IIb); on the other hand, macroscopic type of tumor border was defined based on the histological finding for the area where the marking dot was placed. The presence of diffuse-type adenocarcinoma meant that the lesion was comprised of poorly differentiated adenocarcinoma or signet ring cell carcinoma. The presence of mixed histology meant that the lesion was comprised of more than two histological types (e. g. well-differentiated adenocarcinoma and moderately differentiated adenocarcinoma). A pathologist who was blinded to which group each specimen was assigned performed the judgment of accurate or inaccurate evaluation and detailed assessment of the tumor border.

Outcome measurement
-------------------

Based on the definition previously described, we calculated the rate of accurate evaluation of ME-NBI and chromoendoscopy. As a subgroup analysis, the rates of accurate evaluation according to macroscopic type of EGCs were also calculated and compared. We also analyzed the clinicopathological features of EGCs related to inaccurate endoscopic evaluation of the horizontal extent of the tumor by ME-NBI or by chromoendoscopy.

Statistical analysis
--------------------

This was performed using the chi-squared test or Fisher's exact test for nominal variables. Student's *t* test was used for analysis of continuous variables. All analyses were performed using JMP version 10 (SAS Institute, Tokyo, Japan). *P* values \< 0.05 were considered statistically significant.

Results
=======

A total of 130 lesions (124 patients) out of 276 EGCs (261 patients) treated by ESD in our hospital were enrolled in this study; 67 lesions were assigned to the O-NBI group and 63 to the O-CE group ([Fig. 3](#FI467-3){ref-type="fig"}). One lesion in the O-NBI group and three lesions in the O-CE group were excluded from analysis because the final pathological results of these lesions indicated that they were not adenocarcinoma. Three lesions in the O-NBI group and four lesions in the O-CE group were excluded because sections made in different directions from the direction linking the marking dots on the oral or anal tumor borders were required to assess the resection margins. Five lesions in the O-NBI group and five lesions in the O-CE group were excluded because the marking dots on the tumor border could not be identified by optical microscopy. So the final numbers of analyzable lesions in the O-NBI group and O-CE groups were 58 and 51, respectively.

![ Study enrollment flow chart. One hundred and thirty lesions out of 276 early gastric cancers (EGCs) treated by endoscopic submucosal dissection (ESD) were enrolled in this study; 67 lesions were assigned to the oral narrow-band imaging (O-NBI) group and 63 to the oral chromoendoscopy (O-CE) group. We analyzed the results of 109 lesions (58 lesions from the O-NBI group and 51 lesions from the O-CE group).](10-1055-s-0042-107068-i467ei3){#FI467-3}

There were no statistically significant differences between the background characteristics of the two groups ([Table 1](#TB467-1){ref-type="table"}).

###### Patient and lesion characteristics.

                                                                                                           O-NBI group(n = 58 lesions)   O-CE group(n = 51 lesions)   *P* value
  -------------------------------------------------------------------------------------------------------- ----------------------------- ---------------------------- -----------
  Age (mean ± SD)                                                                                          72.8 ± 8.1                    73.3 ± 9.7                   0.7774
  Gender (male/female)                                                                                     44/12                         29/18                        0.0605
  Tumor size, mean ± SD, mm                                                                                19.9 ± 13.9                   20.7 ± 11.8                  0.7474
  Location Upper Middle Lower                                                                               113017                         72519                      0.6038
  Circumference[1](#FN467-2){ref-type="table-fn"}  Less Gre Ant Post                                        30 41014                      27 611 7                    0.4754
  Macroscopic type 0--I 0--Iia 0--Iib 0--IIc                                                                 125 032                       016 035                    0.2011
  Presence of a flat component Yes No                                                                        454                           249                        0.4968
  Histological type[2](#FN467-3){ref-type="table-fn"}  pap tub1 tub2 por/sig                                14510 2                        03613 2                    0.6270
  Mixture of diffuse-type Yes No                                                                            1048                           843                        0.8273
  Mixed histology Yes No                                                                                    3127                          2625                        0.7969
  Ulceration Yes No                                                                                          751                           447                        0.4649
  Depth M SM1 SM2                                                                                           46 5 7                        38 9 4                      0.3194
  *Helicobacter pylori* infection[3](#FN467-4){ref-type="table-fn"}  Positive After eradication Negative    231315                        191115                      0.8139
  Snare use rate, n/%                                                                                      1/1.72                        0/0.0                        0.3462
  En bloc resection rate, %                                                                                100.0                         100.0                        
  Complete resection rate, %                                                                               93.1                          94.1                         0.8294
  Curative resection rate, %                                                                               77.59                         82.35                        0.5361
  Delayed bleeding, n/%                                                                                    4/7.1                         5/10.6                       0.5315
  Perforation, n/%                                                                                         1/1.8                         0/0.0                        0.3573

O-NBI, oral narrow-band imaging; O-CE, oral chromoendoscopy.Age, gender, delayed bleeding rate, and perforation rate were calculated based on the number of patients, and all remaining items were calculated based on the number of the lesions.

Less = lesser curvature, Gre = greater curvature, Ant = anterior wall, Post = posterior wall.

pap = papillary adenocarcinoma, tub1 = well-differentiated adenocarcinoma, tub2 = moderately differentiated adenocarcinoma, por/sig = poorly-differentiated adenocarcinoma/signet-ring cell carcinoma.

The conditions of *Helicobacter pylori* infection were unclear in five patients in the O-NBI group and two patients in the O-CE group.

Comparison of the accurate evaluation rate of ME-NBI and chromoendoscopy
------------------------------------------------------------------------

After excluding the marking dots which could not be recognized on the resected specimens, 113 marking dots evaluated by ME-NBI and 116 marking dots evaluated by chromoendoscopy were analyzed. The rate of accurate evaluation by ME-NBI (101 /113, 89.4 %) was significantly higher than that by chromoendoscopy (88/116, 75.9 %) (*P* = 0.0071) ([Fig. 4](#FI467-4){ref-type="fig"}). In a subgroup analysis, the rates of accurate evaluation according to macroscopic type of the EGCs were also calculated. There was no significant difference in the rates of accurate evaluation (37/43, 86.1 % by ME-NBI vs 33/41, 80.5 % by chromoendoscopy, *P* = 0.4944) in the Type 0--IIa group. However, in the Type 0--IIc group, the rate of accurate evaluation by ME-NBI (63/69, 91.3 %) was significantly higher than that by chromoendoscopy (54/74, 73.0 %) (*P* = 0.0045).

![ Comparison of the rate of accurate evaluation. The rate of accurate evaluation by ME-NBI (101/113, 89.4 %) was significantly higher than that by chromoendoscopy (88/116, 75.9 %) (*P* = 0.0071). There was no significant difference in the rates of accurate evaluation (37/43, 86.1 % by ME-NBI vs 33/41, 80.5 % by chromoendoscopy, *P* = 0.4944) in the Type 0-IIa group. However, in the Type 0-IIc group, the rate of accurate evaluation by ME-NBI (63/69, 91.3 %) was significantly higher than that by chromoendoscopy (54/74, 73.0 %) (*P* = 0.0045).](10-1055-s-0042-107068-i467ei4){#FI467-4}

Factors related to inaccurate evaluation
----------------------------------------

The rate of inaccurate evaluation by ME-NBI was 10.6 % (12/113). Through univariate analysis, the lesions with flat tumor borders as well as large lesions were significantly more likely to have inaccurate margin assessment ([Table 2](#TB467-2){ref-type="table"}). Multivariate analysis could not be performed because the number of inaccurate markings was insufficient for accurate analysis. The rate of inaccurate evaluation by chromoendoscopy was 24.1 % (28/116). There were no significant factors related to inaccurate evaluation by chromoendoscopy ([Table 3](#TB467-3){ref-type="table"}).

###### Factors related to inaccurate evaluation with ME-NBI (univariate analysis).

                                                                                                           Accurate evaluationn = 101 (89.4 %)   Inaccurate evaluationn = 12 (10.6 %)   *P* value                                                      
  -------------------------------------------------------------------------------------------------------- ------------------------------------- -------------------------------------- ------------------------------------------ ------------------- ----------
  Gender Male Female                                                                                        7130                                   89.9 88.2                              8 4                                       10.111.8           0.7955
  Location Upper  Middle Lower                                                                              164936                                 84.2 87.5 94.7                         3 7 2                                     15.812.5 5.3       0.3531
  Circumference Less Gre  Ant  Post                                                                         48102122                               84.2100.0 91.3 95.7                    9 0 2 1                                   15.8 0.0 8.7 4.4   0.3755
  Macroscopic type 0--I 0--Iia 0--IIc                                                                        13763                                100.0 86.1 91.3                         0 6 6                                      0.014.0 8.7       0.5810
  Presence of a flat component Yes No                                                                        596                                   83.3 89.7                              111                                       16.710.3           0.6212
  Histological type[1](#FN467-5){ref-type="table-fn"}  pap tub1 tub2 por/sig                                 16826 6                              100.0 90.7 83.8100.0                    0 7 5 0                                    0.0 9.316.1 0.0   0.4615
  Mixture of diffuse-type Yes No                                                                            2180                                   87.5 89.9                              3 9                                       12.510.1           0.7362
  Mixed histology Yes No                                                                                    5744                                   89.1 89.8                              7 5                                       10.910.2           0.9002
  Ulceration Yes No                                                                                          992                                   81.8 90.2                              210                                       18.2 9.8           0.3915
  Depth M SM1 SM2                                                                                           751511                                 89.3 88.2 91.7                         9 2 1                                     10.711.8 8.3       1.0000
  *Helicobacter pylori* infection[2](#FN467-6){ref-type="table-fn"}  Positive After eradication Negative    392334                                 88.6 92.0 89.5                         5 2 4                                     11.4 8.010.5       1.0000
  Macroscopic type of tumor border[3](#FN467-7){ref-type="table-fn"}  Elevated Flat Depressed               255422                                100.0 83.1100.0                         011 0                                      0.016.9 0.0       0.0111\*
  Histological type of tumor border pap tub1 tub2 por/sig                                                    26924 6                              100.0 88.5 88.9100.0                    0 9 3 0                                    0.011.511.1 0.0   1.0000
  Marginal elevation[3](#FN467-7){ref-type="table-fn"}  Yes No                                              1388                                   92.9 89.8                              110                                        7.110.2           0.7188
  Age, mean ± SD                                                                                           73.3 ± 9.0                            72.8 ± 7.5                             0.8339                                                         
  Tumor size, mean ± SD, mm                                                                                21.5±13.7                             31.0±17.7                              0.0301[4](#FN467-8){ref-type="table-fn"}                       

ME-NBI, magnifying endoscopy with narrow-band imaging.

pap = papillary adenocarcinoma, tub1 = well-differentiated adenocarcinoma, tub2 = moderately differentiated adenocarcinoma, por = poorly-differentiated adenocarcinoma, sig = signet ring cell carcinoma.

The conditions of *Helicobacter pylori* infection were unclear in five patients in the accurate evaluation group and one patient in inaccurate evaluation group.

Macroscopic type of tumor border and marginal elevation were not able to be judged in one lesion in the inaccurate evaluation group because of the burning effect.

*P* \< 0.05.

###### Factors related to inaccurate evaluation with chromoendoscopy (univariate analysis).

                                                                                                           Accurate evaluationn = 88 (75.9 %)   Inaccurate evaluationn = 28 (24.1 %)   *P* value                       
  -------------------------------------------------------------------------------------------------------- ------------------------------------ -------------------------------------- ----------- ------------------- --------
  Gender Male Female                                                                                        6028                                  74.1 80.0                             21 7        25.920.0           0.4936
  Location Upper Middle Lower                                                                               164032                                84.2 69.0 82.1                         318 7      15.831.018.0       0.2181
  Circumference Less Gre  Ant Post                                                                          43102015                              71.7 83.3 87.0 71.4                   17 2 3 6    28.316.713.028.6   0.4379
  Macroscopic type 0--I 0--IIa 0--IIc                                                                        13354                               100.0 80.5 73.0                         0 820       0.019.527.0       0.6183
  Presence of a flat component Yes No                                                                        385                                  75.0 75.9                              127        25.024.1           0.9673
  Histological type pap tub1 tub2 por/sig                                                                    16520 2                             100.0 80.3 69.0 40.0                    016 9 3    0.019.831.060.0    0.1153
  Mixture of diffuse-type Yes No                                                                            1573                                  68.2 77.7                              721        31.822.3           0.3497
  Mixed histology Yes No                                                                                    4741                                  77.1 74.6                             1414        23.025.5           0.7530
  Ulceration Yes No                                                                                          880                                  57.1 78.4                              622        42.921.6           0.0809
  Depth M SM1 SM2                                                                                           6812 8                                77.3 70.6 72.7                        20 5 3      22.729.427.3       0.7013
  *Helicobacter pylori* infection[1](#FN467-9){ref-type="table-fn"}  Positive After eradication Negative    312029                                70.5 76.9 78.4                        13 6 8      29.623.121.6       0.6861
  Macroscopic type of tumor border[2](#FN467-10){ref-type="table-fn"}  Elevated Flat Depressed              205414                                87.0 77.1 66.7                         316 7      13.022.933.3       0.2770
  Histological type of tumor border pap tub1 tub2 por/sig                                                    26718 1                             100.0 77.0 72.0 50.0                    020 7 1     0.023.028.050.0   0.6024
  Marginal elevation[2](#FN467-10){ref-type="table-fn"}  Yes No                                             1375                                  81.3 76.5                              323        18.823.5           0.6766
  Age, mean ± SD                                                                                           72.9 ± 8.5                           71.4 ± 9.9                             0.4367                          
  Tumor size, mean ± SD, mm                                                                                21.6 ± 13.5                          24.9 ± 15.3                            0.2744                          

The conditions of *Helicobacter pylori* infection were unclear in eight patients in the accurate evaluation group and one patient in the inaccurate evaluation group.

Macroscopic type of tumor border and marginal elevation were not able to be judged in two lesions in the inaccurate evaluation group because of the burning effect.

Discussion
==========

Recently, ME-NBI has gradually become popular in the clinical setting. In this study, we objectively compared the usefulness of ME-NBI and chromoendoscopy for determining the horizontal extent of EGCs through precise correlation between endoscopic and pathological findings. As a result, the rate of accurate evaluation by ME-NBI was significantly higher than that by chromoendoscopy. The delineation of tumor borders with chromoendoscopy is performed based on mucosal elevation/depression enhanced by indigo carmine, but these findings often arise as a consequence of inflammation or intestinal metaplasia.

In contrast, the delineation of tumor borders with ME-NBI is performed based on the specific findings of the tumor, such as microvascular or microsurface pattern. So observation with ME-NBI might be able to delineate EGCs more accurately than with chromoendoscopy.

Our study suggested that a large tumor size and a flat tumor border were significant factors which were related to inaccurate endoscopic evaluation of the horizontal extent of EGCs using ME-NBI.

These factors may lead to inaccurate evaluation due to the technical aspects of ME-NBI. For ME-NBI at full magnification, the endoscope must come in contact with the surface of the gastric mucosa. Thus, during the process of delineating the tumor border with ME-NBI, the endoscope inevitably comes in continuous contact with the surrounding mucosa, leading to contact bleeding and other mucosal damage. In addition, observation using ME-NBI is time-consuming because, at a magnification of × 80, only a small area can be observed at one time. The influence of mucus secretion from gastric mucosa caused by water flushing and contact of the scope may become greater with time. Large lesions generally require close-up observation of a wider area and long observation time for delineation, which may lead to contact bleeding and/or mucus secretion, complicating endoscopic evaluation. Lesions with a flat tumor border may also tend to require observation of a wider area and long observation time for delineation because of the difficulty to decide where to observe by ME-NBI. Thus, these lesions might be more open to the influence of contact bleeding and/or mucus secretion.

On the other hand, with chromoendoscopy, endoscopists identify the tumor borders from a middle distance view during a relatively short time, which may be why the results of chromoendoscopy were not influenced by these factors.

Among lesions with an elevated or depressed tumor border, the rate of accurate evaluation by ME-NBI was 100 %. However, with chromoendoscopy, evaluation was inaccurate in 13 % of elevated types and 33 % of depressed types. Although mucosal elevation/depression at the tumor border and intralesional mucosal irregularity is enhanced by indigo carmine, the background gastric mucosa surrounding EGC is often uneven because of inflammation or intestinal metaplasia. It may have been difficult to distinguish the elevation/depression of the tumor border from those due to inflammation or intestinal metaplasia by chromoendoscopy. On the other hand, ME-NBI may be able to distinguish these mucosal alterations by observation of microvascular and microsurface patterns.

It has been reported that the tumor borders of diffuse-type EGCs are often difficult to delineate even with ME-NBI, although no diffuse-type lesion was inaccurately evaluated in our study. By pathological assessment, tumor cells were observed at the surface of the mucosa at the tumor edge in all cases. This was one reason why we could accurately delineate the diffuse-type EGCs. The number of diffuse-type EGCs was too small in our study, thus a systematic analysis of the usefulness of ME-NBI in delineating diffuse-type EGCs is required.

The limitations of this study are as follows. First, it is possible that the operators marked the most easily distinguishable delineation point of the tumor border within the range of oral or anal side, because the protocol for the location of marking was not strictly established. The objectivity of this study may have been improved if the location of the marking had been defined as the most oral or anal edge of the tumor.

Second, the subjects of this study did not cover all EGCs. We excluded EGCs located in the greater curvature of the gastric body to remove the influence of inaccurate marking due to respiratory fluctuation. However, we have previously reported that the rate of accurate evaluation of the horizontal extent of EGCs was not influenced by tumor location or the circumference [@JR467-18]. Thus, it would appear that it is possible to extrapolate the results of this study to EGCs located in the greater curvature of the gastric body. We also excluded EGCs less than 10 mm in diameter because the entire tumor border would be visible during evaluation with ME-NBI, influencing the evaluation with chromoendoscopy. In addition, this exclusion criterion could also prevent the underestimation of chromoendoscopy accuracy due to contact bleeding during the observation with ME-NBI. There is a high possibility that the results of this study can be extrapolated to these EGCs because tumor delineation is easier in small EGCs as we have also reported previously [@JR467-18]. We excluded cancers of a remnant stomach or a gastric tube and residual cancers after endoscopic treatment to remove the influence of previous treatment and to focus only on the clinicopathological features of EGCs. The usefulness of ME-NBI and chromoendoscopy for determining the horizontal extent of these lesions is a subject of future investigation.

In conclusion, the rate of accurate evaluation of the horizontal extent of EGCs by ME-NBI is significantly higher than that by chromoendoscopy. However, accurate evaluation is still difficult in large EGCs and EGCs with flat tumor borders, even with ME-NBI. A more careful approach using more than one modality may be advisable for these EGCs.
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